Dublin, Oct. 09, 2025 (GLOBE NEWSWIRE) -- The "Orally Disintegrating Tablet Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By ...
(RTTNews) - Viatris (VTRS) announced the launch in Canada of Gen-Clozapine orally disintegrating tablets, providing a new treatment option for treatment-resistant schizophrenia patients. This marks ...
Please provide your email address to receive an email when new articles are posted on . MindMed will use Catalent’s Zydis orally disintegrating tablet technology for the development of MM-120, an ...
HERTFORDSHIRE, England and PITTSBURGH, Nov. 24, 2015 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Clozapine Orally Disintegrating Tablets, 25 mg and 100 mg, the ...
Granules India received tentative USFDA approval for Amphetamine Extended-Release Orally Disintegrating Tablets, offering 180 ...
Please provide your email address to receive an email when new articles are posted on . APT-1011, a novel fluticasone orally disintegrating tablet, effectively induced histologic response, improved ...
Pharmaceutical giant Pfizer is developing new packaging for one of its prescription drugs after discovering it didn't meet child-resistant requirements, and could pose a poisoning risk. Pfizer is ...
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback